Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018

Abstract Background Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis. However, limited availability to buprenorphine is pervasive in the United States (US) and may serve to exacerbate the deadl...

Descrición completa

Detalles Bibliográficos
Main Authors: Kevin P. Conway, Dalia Khoury, Rainer Hilscher, Arnie P. Aldridge, Stephanie J. Parker, Gary A. Zarkin
Formato: Artigo
Idioma:English
Publicado: BMC 2022-01-01
Series:Addiction Science & Clinical Practice
Subjects:
Acceso en liña:https://doi.org/10.1186/s13722-021-00282-2